BRIEF published on 10/31/2024 at 07:35, 21 days 6 hours ago AIXTRON Shows Stable Q3 Performance Amidst Challenging Market Conditions Market Conditions Financial Guidance Order Intake Increase Q3 Revenues SiC And GaN Progress
PRESS RELEASE published on 10/31/2024 at 07:30, 21 days 7 hours ago AIXTRON delivers robust Q3 despite weak market environment AIXTRON report strong Q3 results despite market challenges with revenues of EUR 156.3 million, order intake up 21% year-on-year, and technological advancements in SiC and GaN systems Revenues Order Intake Q3 Results AIXTRON Technological Advancements
BRIEF published on 09/17/2024 at 07:35, 2 months 4 days ago AIXTRON Extends CEO Dr. Felix Grawert's Contract to 2030 AIXTRON Power Electronics CEO Contract Felix Grawert Optoelectronics
PRESS RELEASE published on 09/17/2024 at 07:30, 2 months 4 days ago AIXTRON renews contract of CEO Dr. Felix Grawert AIXTRON renews CEO Dr. Felix Grawert's contract for five more years, highlighting his pivotal role in the company's growth and success in the semiconductor industry Semiconductor Industry CEO Contract Renewal AIXTRON Dr. Felix Grawert
BRIEF published on 07/25/2024 at 07:35, 3 months 27 days ago AIXTRON Reports Strong Order Intake in Q2 2024 Financial Results Order Intake Q2 2024 AIXTRON Semiconductor
PRESS RELEASE published on 07/25/2024 at 07:30, 3 months 27 days ago AIXTRON delivers strong order intake in Q2 AIXTRON SE announces strong order intake in Q2, matching previous year's revenues. SiC and GaN power momentum continues. Production capacity expansion in Italy. Guided for adjusted 2024 results Revenues Order Intake 2024 Guidance AIXTRON SE Production Capacities
BRIEF published on 07/16/2024 at 07:35, 4 months 5 days ago Nexperia Partners with AIXTRON for 200mm SiC and GaN Power AIXTRON Semiconductors SiC GaN Nexperia
PRESS RELEASE published on 07/16/2024 at 07:30, 4 months 5 days ago Nexperia partners with AIXTRON for 200mm SiC and GaN power AIXTRON SE supports Nexperia B.V. in ramping up 200mm production for SiC and GaN power devices, enhancing semiconductor capabilities. Strategic partnership aims for energy-efficient technologies AIXTRON SE Semiconductor Production SiC GaN Nexperia B.V.
BRIEF published on 07/04/2024 at 23:22, 4 months 16 days ago AIXTRON Reports Preliminary Q2/2024 Results with Strong Order Intake Order Intake AIXTRON SiC GaN Q2/2024
BRIEF published on 07/04/2024 at 23:20, 4 months 16 days ago AIXTRON SE Reports Preliminary Q2/2024 Results and Adjusts FY 2024 Guidance Revenue EBIT Margin Forecast AIXTRON SE Q2/2024
Published on 11/21/2024 at 14:15, 16 minutes ago neurocare Group AG Welcomes Kevin Reeder as Chief Financial Officer
Published on 11/21/2024 at 14:00, 31 minutes ago Demotech, Inc. Assigns a Financial Stability Rating(R) of A, Exceptional, to Steadily Insurance Company
Published on 11/21/2024 at 14:00, 31 minutes ago Montara Raises $5.4M to Help Organizations Deliver Better Data Products Faster
Published on 11/21/2024 at 14:00, 31 minutes ago Tevir Capital LP Ltd. Updates Early Warning Reporting in Respect of VerticalScope Holdings Inc.
Published on 11/21/2024 at 14:16, 15 minutes ago EQS-Adhoc: LM PAY S.A. Announces Third Quarter 2024 Preliminary Results and Updated Guidance
Published on 11/21/2024 at 14:15, 16 minutes ago ZenaTech Signs Blue UAS and NDAA Compliant Supply Chain Partners to Sell to US Defense Branches and NATO Forces
Published on 11/21/2024 at 12:35, 1 hour 56 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 06:58, 7 hours 33 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 19 hours 11 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 20 hours 46 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 20 hours 46 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 6 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
